Document:

Prepared by R.R. Donnelley Financial -- Form of Research And Development Agreement

  EXHIBIT 10.8 
   
 RESEARCH AND DEVELOPMENT AGREEMENT 
  
 This RESEARCH AND
DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of             
                    , 2002 between CarnaudMetalbox plc, a public limited company formed under the laws of England and Wales
(“Carnaud”), Crown Cork & Seal Technologies Corporation (“Crown Technologies” and, collectively with Carnaud, the “Crown Entities”) and Constar, Inc., a Delaware corporation (“Constar,
Inc.”). 
  
 BACKGROUND 
  
 A.    The Crown Entities currently provide certain research and development services to Constar, Inc. 
  
 B.    Crown Cork & Seal Company, Inc. (“Crown”) and Constar International Inc.
(“Constar”) are contemplating that an initial public offering will be made of all of the capital stock of Constar (the “Initial Public Offering”), and Crown and Constar, Inc. both desire for the Crown Entities to
continue to provide certain services to Constar, Inc. following the Initial Public Offering. 
  
 C.    The Crown Entities and Constar, Inc. desire to enter into this Agreement to set forth the roles and responsibilities with regard to research and development services to be provided by the Crown Entities to
Constar, Inc. following the Initial Public Offering. 
  
 TERMS 
  

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Crown Entities and Constar, Inc., for themselves
and their successors and assigns, and intending to be legally bound hereby, hereby agree as follows: 
  
 1.  Definitions.    Capitalized terms not defined in this Agreement shall have the meanings ascribed to them in the Corporate Agreement, dated as of the date hereof, between Crown and Constar. As
used in this Agreement, the following terms shall have the respective meanings set forth below: 
  
 1.1.  “AAA” shall have the meaning set forth in Section 13.5. 
  
 1.2.  “Additional Services” shall have the meaning set forth in Section 2.4 below. 
  
 1.3.  “Benefits Allocation Agreement” shall mean the Benefits Allocation Agreement, dated as of the date hereof, between Crown and Constar. 

  
 1.4.  “Commitment Percentage” shall
have the meaning set forth in Section 2.1 below. 
  
 1.5.  “Commitment
Period” shall have the meaning set forth in Section 2.1 below. 
  
 1.6.  “Confidential Information” shall have the meaning set forth in Section 8 below. 
  
 1.7.  “Costs” shall have the meaning set forth in Section 3.1 below. 
  
 1.8.  “Developed Intellectual Property” shall have the meaning set forth in Section 6.1 below. 
  
 1.9.  “Force Majeure Event” shall have the meaning set forth in Section 13.2 below. 
  
 1.10.  “Key Carnaud Individuals” shall mean the individuals specified as such on Schedule
A and/or such other individuals that are designated as Key Carnaud Individuals by the parties pursuant to Section 2 from time to time. 
  
 1.11.  “Key Crown Individuals” shall mean the individuals specified as such on Schedule A and/or such other individuals that are designated as Key Crown Individuals by
the parties pursuant to Section 2 from time to time. 
  
 1.12.  “Key
Individuals” shall mean the Key Crown Individuals, the Key Carnaud Individuals and the Key Transferred Individuals and/or such other individuals that are designated as Key Individuals by the parties pursuant to Section 2 from time to time.

  
 1.13.  “Key Transferred Individuals” shall mean the individuals
specified as such on Schedule A and/or such other individuals that are designated as Key Transferred Individuals by the parties pursuant to Section 2 from time to time. 
  
 1.14.  “Key Individual Fees” shall have the meaning set forth in Section 2.1 below. 
  
 1.15.  “Key Individual Services” shall mean the reasonable services, consistent with past
practice of the Crown Entities with respect to similar projects, performed for Constar, Inc. by Key Individuals in accordance with and subject to this Agreement. 
  
 1.16.  “Non-Dedicated Equipment” shall have the meaning set forth in Section 2.3 below. 
  
 1.17.  “Proprietary Rights” shall mean any intellectual property and other proprietary rights,
including, without limitation, any patents, patent applications, industrial design rights, copyrights (and any registration or applications therefor), database rights, trade secrets, all other rights in and to any inventions, discoveries, processes,
formulae, technology, works of authorship and any writings, diagrams, computer programs, compilations and pictorial representations and other works (whether or not copyrightable) relating thereto. 
  
 1.18.  “R&D Fees” shall mean Key Individual Fees and any fees payable for Additional
Services. 
  
 1.19.  “R&D Services” shall mean Additional Services and
Key Individual Services. 
  
 1.20. “Term” shall have the meaning set forth in
Section 5 below. 
  
 2.  Services. 
  2.1.  Key Individuals.    During the Term, and during the Commitment Period for each Key Individual set forth on
Schedule A (the “Commitment Period”), the applicable Crown Entity under whose name such Key Individual is listed on Schedule A shall make such Key Individual available to provide such support and assistance to Constar,
Inc. as is consistent with the skills and experience of such Key Individual, for the applicable percentage of the Key Individual’s working hours per month that is indicated on, and modified in accordance with the terms set forth on, Schedule
A (the “Commitment Percentage”). Constar, Inc. shall have the right to approve the activities of Key Carnaud Individuals and the Key Crown Individuals while providing Key Individual Services in a manner consistent with the
skills and experience of such Key Individuals and shall define and approve the scope of Key Individual Services provided by Key Individuals pursuant to this Agreement. In consideration for such access to each Key Individual, Constar, Inc. agrees to
pay the applicable Crown entity under whose name such Key Individual is listed on Schedule A (i) a fee for each Key Transferred Individual equal to (x) the actual cost to the Crown Entities of compensation and benefits to such Key Individual
per month for each month during which access is provided to such Key Individual plus (y) an annual overhead charge of $[***], plus phone, delivery and courier costs actually incurred by a Crown Entity, prorated and payable on a monthly basis and
(ii) a fee per each Key Carnaud Individual and Key Crown Individual equal to the product of (x) $[***] per month for each month during which access is provided to a Key Individual multiplied by (y) such Key Individual’s Commitment Percentage
(collectively, “Key Individual Fees”). The Key Individuals shall, subject to the terms of this Agreement and the Benefits Allocation Agreement, at all times remain employees of the applicable Crown Entity, or one of its Affiliates,
and shall remain subject to the applicable Crown Entity’s policies applicable to its employees. The Crown Entities’ obligation under this Agreement to make a given Key Individual available to Constar, Inc. and the Constar Entities’
obligation to pay Key Individual Fees shall continue for the duration of such Key Individual’s Commitment Period, except that in no event shall such obligations continue beyond the Key Individual’s employment with the applicable Crown
Entity. In the event that a Key Individual ceases to be an employee of the applicable Crown Entity for any reason during the Term other than by taking up employment with Constar, Inc., the applicable Crown Entity shall make commercially reasonable
efforts to find a qualified replacement, whom the applicable Crown Entity may then, with Constar, Inc.’s prior written consent designate as a Key Individual for purposes of this Agreement, to be treated as if such individual were the replaced
Key Individual under the terms of this Agreement; provided, that the applicable Crown Entity shall not be deemed to be in breach of this Agreement (a) if the applicable Crown Entity is unable to hire a qualified replacement for any reason or
(b) as a result 
  

	[***]
	 
	Confidential treatment requested 
 

 
of any delay of whatever duration in the hiring of a qualified replacement. In the event that Constar, Inc. does not consent to a replacement being designated as a Key Individual, neither the
applicable Crown Entity nor any of its Affiliates shall be obligated to provide, or otherwise arrange for the provision of, the Key Individual Services that were previously provided under this Agreement by the Key Individual whose employment with
the applicable Crown Entity has terminated and the applicable Crown Entity shall not be deemed to be in breach of this Agreement. In the event that a Key Individual ceases to be an employee of the applicable Crown Entity for any reason, the
Commitment Period for such Key Individual shall end; provided, that if such Key Individual is replaced pursuant to this Section 2.1, the replacement Key Individual shall assume the balance of the replaced Key Individual’s Commitment
Period. 
  
 2.2.  Activity Reports.    Within 30 days after the
end of each calendar month during the Term, the applicable Crown Entity shall provide Constar, Inc. with monthly reports (based on, and in accordance with, the applicable Crown Entity’s then existing reporting system) on the availability during
such month of Key Individuals to provide Key Individual Services and all Key Individual Services actually provided under this Agreement. In connection with such monthly reports, Key Individuals shall keep a log setting forth the time each such Key
Individual worked in performing the Key Individual Services under this Agreement which shall be supported by weekly time allocation reports with details to be mutually agreed, reviewed by the Constar, Inc. Vice President of Research and Development
or his designee. Any charges above the applicable Commitment Percentage of any Key Individual must be approved by the Constar, Inc. Vice President of Research and Development or his designee in advance. The applicable Crown Entity shall from time to
time provide Constar, Inc. with meeting records, technical records and project review presentations relating to the Key Individual Services provided in connection with Constar, Inc. projects as reasonably appropriate and in accordance with past
practices and in accordance with such reasonable protocols and procedures as the Parties shall mutually agree. So long as the Crown Entities make Key Individuals available to Constar, Inc. in accordance with Section 2.1, Constar, Inc. shall pay the
full Key Individual Fees regardless of the actual time spent on Key Individual Services during any month. Constar, Inc. shall from time to time provide the applicable Crown Entity with meeting records and technical records relating to Constar,
Inc.’s services to Crown as reasonably appropriate and in accordance with past practices and in accordance with such reasonable protocols and procedures as the parties shall mutually agree. 
  

2.3.  Resources. 
  
 (a)  During the Term, Crown shall have no right to use and no right to access the Constar, Inc. owned equipment for any other purpose than the research and development services rendered under
this agreement for Constar, Inc. However, when mutually agreed, Constar, Inc. will use commercially reasonable efforts to provide Crown with R&D services at the same standard billing rate and other terms, including, without limitation, warranty
and indemnification, provided in this Agreement as used by Crown for Additional Services to Constar, Inc. 
 

  
 (b)  During the Term, the Crown Entities shall make
available to the Key Individuals, the non-dedicated equipment set forth on Schedule B (the “Non-Dedicated Equipment”) to the extent necessary for performance of the Key Individual Services on a reasonable basis during normal
business hours or such hours as the parties shall mutually agree, and in accordance with such reasonable protocols and procedures as the parties shall mutually agree from time to time; provided, that the Crown Entities shall not be obligated
to make Non-Dedicated Equipment available for Key Individual Services to the extent that such Non-Dedicated Equipment is reasonably required for other activities of the Crown Entities or their Affiliates. Nothing in this Agreement shall require the
Crown Entities to develop or acquire any facilities or equipment other than as exists as of the Initial Public Offering Date. In lieu of the then existing Non-Dedicated Equipment, the applicable Crown Entity may, in its sole discretion, from time to
time make available to the Key Individuals equivalent alternative equipment, which equipment shall be deemed to be Non-Dedicated Equipment. 
  
 (c)  The Crown Entities shall permit employees of Constar, Inc. to visit the facilities where Key Individual Services are performed. Any such visits shall be reasonable in scope and duration
and shall be conducted during normal business hours. 
  
 (d)  In consideration for the
R&D Fees provided herein, Carnaud agrees to allow Constar, Inc. to store and use the equipment identified on Schedule C in Carnaud’s Wantage facility, consistent with historical practices in Wantage, until the date which is 3 months
from the Initial Public Offering Date or to charge a reasonable fee to be mutually agreed for an extended period of storage. 
  
  2.4.  Additional Services.    The Crown Entities will use commercially reasonable efforts to provide Constar, Inc. with (a) research and development services other
than the Key Individual Services and (b) Key Individual Services in excess of a Key Individual’s Commitment Percentage during any month (collectively, “Additional Services”). Such Additional Services shall be provided at the
Crown Entities’ standard billing rate [***], prorated for the amount of time spent providing Additional Services. In the event that Constar, Inc. receives Key Individual Services from a Key Individual that exceed such Key Individual’s
Commitment Percentage during a month, such excess Key Individual Services shall be considered Additional Services. 
   
 2.5.  Oxygen Transmission Measuring Machines (Illiop). 
  
 (a)  Crown Technologies will complete construction of a new Illiop machine prior to the termination of this agreement, which shall be included as Non-Dedicated Equipment and owned by Crown. Within 90 days after such new
Illiop machine is deemed fully operational by Crown Technologies, Crown shall transfer ownership of the existing Illiop machine in Alsip that is included among the Non-Dedicated Equipment to Constar, Inc. 
  
 (b)  Constar, Inc. and Crown shall make all Illiop machines available to each other on a reasonable basis during
normal business hours or such hours as the parties shall 
 

	[***]
	 
	Confidential treatment requested 
 

  

 
mutually agree, and in accordance with such reasonable protocols and procedures as the parties shall mutually agree from time to time. 
  

2.6.  Employees.    Notwithstanding the provisions of the Non-Competition Agreement between Crown and Constar,
Constar, Inc. shall have the option [***] as indicated on Schedule A. After the Initial Public Offering Date, and on 45 days notice, Constar, Inc. and the Crown Entities can mutually agree to modify the Commitment Percentage or the Commitment
Period, or Constar, Inc. can [***]. Beginning 90 days after the Initial Public Offering Date, Constar, Inc. may, at its option, [***]. Crown agrees to extend the Commitment Period with regard to [***] upon Constar, Inc.’s request at terms to be
mutually agreed. Constar, Inc. shall inform the Crown Entities of its intention [***]. 
   
 3.  Payment for Costs. 
  
 3.1.  Constar, Inc. shall
reimburse the Crown Entities for all third party costs that the Crown Entities incur in connection with the performance of the R&D Services and for which Crown has obtained written prior approval from Constar, Inc. (the
“Costs”), including, by way of example without limitation, equipment repair and maintenance, materials costs, subcontractor costs, and reasonable travel and accommodation expenses. Without limiting the foregoing Constar, Inc. shall
reimburse the applicable Crown Entity for any and all costs associated with repair of equipment that is damaged, becomes inoperable, or otherwise malfunctions specifically because of the use of such equipment in performing the R&D Services.

  
 4.  Invoicing and Payment. 
  

4.1.  The Crown Entities shall present invoices for R&D Fees and Costs to Constar, Inc. on a monthly basis. All R&D Fees and Costs
shall be due within thirty (30) days of receipt of an invoice therefor. 
  
 4.2.  The Crown
Entities shall keep reasonably accurate and timely books and records relating to the R&D Fees and Costs in accordance with the Crown Entities’ standard record-keeping procedures and which shall be supported by purchase approval documents
and weekly timekeeping reports available to the Constar, Inc. Vice President of Research and Development or his designate, and shall maintain such books and records until one year after the termination or expiration of this Agreement. Constar, Inc.
shall have the right, during the Term, at Constar, Inc.’s own expense, to audit the Crown Entities’ books and records for the purpose of verifying the R&D Fees and Costs. Such audits shall be made not more than once per year, on not
less than 15 days’ written notice, during regular business hours and by independent auditors selected by Constar, Inc. and acceptable to the Crown Entities, such acceptance not to be unreasonably withheld, conditioned or delayed. In the event
such audit reveals any inaccuracies in the R&D Fees and Costs reported by the Crown Entities, the parties shall take action promptly to correct 
 

	[***]
	 
	Confidential treatment requested 
 

  

 
such inaccuracies, including, without limitation, the payment or refund, as the case may be, of R&D Fees and Costs to the extent that the amount actually paid by Constar, Inc. is more or less
than the amount accurately due. 
  
 4.3. All sums referenced in this Agreement are expressed
exclusive of VAT or other sales tax, which shall be paid by Constar, Inc. at the time and manner prescribed by law. 
  
 5.  Term. 
  
 5.1.  The term of this Agreement
shall begin on the Initial Public Offering Date and, unless terminated as provided for herein, shall continue until December 31, 2003 (the “Term”). The Term of this Agreement can be extended beyond this date, if mutually agreed by
Constar, Inc. and the Crown Entities. 
  
 5.2.  The following shall be considered events of
default and shall give rise to a right of either Crown Entity to terminate this Agreement: (i) Constar, Inc. fails to make timely payments for invoiced R&D Fees and Costs, subject to a 30-day cure period after notice regarding such breach, (ii)
Constar, Inc. materially breaches any other applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such breach, or (iii) Constar or Constar, Inc. experiences a change of Control such that Constar or Constar,
Inc. is controlled by a competitor of Crown or Constar, Inc. (provided that such termination shall not be effective until six months from the date of the change of Control). If Constar or Constar, Inc. suffers a Bankruptcy Event, Crown shall have
the right to unilaterally modify the payment terms set forth in Section 4.1 of the Agreement at any time after such Bankruptcy Event. Crown shall promptly notify Constar, Inc. of any such modifications to the payment terms of this Agreement.

  
 5.3.  The following shall be considered events of default and shall give rise to a
right of Constar, Inc. to terminate this Agreement: (i) either Crown Entity materially breaches any other applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such breach or (ii) either Crown Entity or Crown
experiences a change of Control such that either Crown Entity or Crown is controlled by a competitor of Constar, Inc. or Crown (provided that such termination shall not be effective until six months from the date of the change of Control).

  
 6.  Intellectual Property. 
  

6.1.  As between the Crown Entities and Constar, Inc., Constar, Inc. shall own all right, title and interest in and to any Proprietary Rights
that are developed, generated or created in the performance of the R&D Services (the “Developed Intellectual Property”). Notwithstanding anything to the contrary in this Agreement, Developed Intellectual Property shall not
include any Proprietary Rights that either of the Crown Entities hold or own prior to, or as a result of activities other than, performance of the R&D Services, and as between the Crown Entities and Constar, Inc., the Crown Entities own and at
all times shall own all right, title and interest in and to such Proprietary Rights and to any improvements or modifications of such Proprietary Rights. The Crown Entities hereby irrevocably and unconditionally assign and transfer to Constar, Inc.
 
 

 
all rights of every kind, nature or description, whether now known or hereafter devised, that the Crown Entities may have in or to such Developed Intellectual Property. The Crown Entities shall,
at Constar, Inc.’s request, obtain, execute and deliver such other instruments and documents, in form and substance reasonably satisfactory to Constar, Inc., as may be necessary to further evidence, perfect, maintain and effectuate the rights
granted to Constar, Inc. hereunder, including without limitation causing the Key Individuals and/or any other inventors to execute and deliver such assignments and inventions disclosures as may be necessary to transfer the Developed Intellectual
Property to Constar, Inc. In addition, at Constar, Inc.’s request and expense, Crown shall provide reasonable cooperation to Constar, Inc. in the event that Constar, Inc. elects at its discretion to file and prosecute any patent applications as
part of the Developed Intellectual Property. 
  
 6.2.  For Developed Intellectual Property,
Constar, Inc. will bear all patent filing fees, renewal fees, and external legal fees. For Developed Intellectual Property, the Crown Entities will charge as Additional Services any labor costs incurred by Crown Entities personnel in the preparation
and filing for registered patent and trademark protection. 
  
 7.  Warranty; Limitation
of Liability. 
  
 7.1.  The Crown Entities warrant that the R&D Services shall be
performed in a workmanlike manner. In the case of any work which is not in compliance with this warranty that is brought to its attention within a commercially reasonable time, but no more than 90 days, after the work is performed, the Crown
Entities agree (i) to refund to Constar, Inc. any charges for services or materials pertaining to such work or (ii) to re-perform the work. OTHER THAN THE ABOVE WARRANTY, THE CROWN ENTITIES MAKE NO WARRANTY, WHETHER OF MERCHANTABILITY, FITNESS OR
OTHERWISE, EXPRESS OR IMPLIED, IN FACT OR BY LAW, AND THE CROWN ENTITIES SHALL HAVE NO FURTHER OBLIGATION OR LIABILITY UNDER THE ABOVE WARRANTY OR WITH RESPECT TO THE R&D SERVICES. THE CROWN ENTITIES SHALL IN NO EVENT BE LIABLE FOR PUNITIVE,
CONSEQUENTIAL OR INCIDENTAL DAMAGES. 
  
 7.2.  Subject to the above provisions, Constar,
Inc. shall not bring any other action arising hereunder unless such action is brought within one year after the date such cause of action accrues. 
  
 7.3.  The Crown Entities shall not be liable for, and Constar, Inc. assumes responsibility for, all personal injury and property damage resulting
from the provision of R&D Services hereunder, except to the extent any such personal injury or property damage results from the willful misconduct of the Crown Entities. 
  
 8.  Confidentiality; Disclosures. 
  
 8.1.  Confidentiality. Each party agree (a) to maintain all information, whether in written, oral, electronic or other form, necessary for or utilized or received by such party
 
 

 
pursuant to any terms of this Agreement, as the case may be, including, without limitation, prices, payment terms, technical knowledge, know-how, material, manufacturing, Proprietary Rights,
tooling and equipment specifications and other information necessary to carry out the terms of this Agreement and any proprietary or confidential inventions, discoveries, processes, formulae or technology developed, generated or created in the
performance of the R&D Services, as the case may be (the “Confidential Information”), as secret and confidential and (b) not to disclose the Confidential Information to any third person or party (except for employees, counsel,
contractors, customers, consultants or vendors who have a need to know and are informed of the confidential nature of such information by the disclosing party). Each party shall accept responsibility and be liable for any disclosure by any third
person of any Confidential Information disclosed to such third person by such party. The parties will use the same measures to maintain the confidentiality of the Confidential Information of any other party in its possession or control that it uses
to maintain the confidentiality of its own Confidential Information of similar type and importance.  Notwithstanding the foregoing, any party or their Affiliates may describe this Agreement in, and include this Agreement with, filings with
the U.S. Securities and Exchange Commission and any related prospectuses, including such filings or prospectuses in connection with any offering of securities. Confidential Information will not include information that (i) is in or enters the public
domain without breach of this Agreement, or (ii) the receiving party lawfully receives from a third party without restriction on disclosure and, to the receiving party’s knowledge, without breach of a nondisclosure obligation. 

 
 8.2.  Disclosure to Governmental Agency. Notwithstanding the foregoing, each party shall be
permitted to disclose the Confidential Information and/or any portion thereof (i) to a governmental agency or authority as required in response to a subpoena therefor, (ii) in connection with formal requests for discovery under applicable rules of
civil procedure in a legal action before a court of competent jurisdiction to which such party is a party and (iii) as otherwise required by law; provided, however, that, in any such case, each party shall notify the other party as
early as reasonably practicable prior to disclosure to allow such party to take appropriate measures to preserve the confidentiality of such information at the expense of such party. 
  
 8.3.  Ownership of Information. All Confidential Information supplied or developed by either party will be and remain the sole and
exclusive property of the party who supplied or developed it. Nothing in this Section 8.3 shall derogate Constar, Inc.’s ownership rights in Developed Intellectual Property as provided in Section 6. 
  
 8.4.  Return of Confidential Information. Upon the written request of a party which has disclosed
information covered by this Section 8 in written, printed or other tangible form, all such readily available information, all copies thereof, including samples or materials, and all notes or other materials derived from such information shall be
returned to the party which disclosed such information. 
  
 9.  Independent
Contractors.    None of the parties is now, nor shall it be made by this Agreement, an agent or legal representative of any other party for any purpose, and no party has
 
 

 
any right or authority to create any obligation, express or implied, on behalf of any other party, to accept any service of process upon it, or to receive any notices of any kind on its behalf.
All activities by the Crown Entities hereunder shall be carried on by the Crown Entities as independent contractors and not as agents for Constar, Inc. 
  
 10.  Security.    Crown will provide commercially reasonable physical protection and shall put in place commercially
reasonable procedures to restrict access by unauthorized persons to the Constar, Inc. work area, documents, work product, laboratory and equipment environment, and to all forms of access to computerized information by unauthorized persons. Crown
shall not be responsible or liable for any breach of security that arises out of conduct by Constar, Inc.’s employees, counsel, contractors, consultants or vendors. Access to Constar, Inc. restricted areas and sources of information must be
made only upon authorization by Constar, Inc.’s Vice President of Research and Development (or a designee) for any third person or party who is not an employee, counsel, contractor, consultant or vendor of Constar, Inc. with a project-related
need to such access and who has not executed a confidentiality agreement which conforms to the requirements of Section 8 above concerning confidentiality. Access to Crown Entity restricted areas and sources of information must be made only upon
authorization by Crown’s Executive Vice President of Research and Development (or a designee) for any third person or party who is not an employee, counsel, contractor, consultant or vendor of Crown with a project-related need to such access
and who has not executed a confidentiality agreement which conforms to the requirements of section 8 above concerning confidentiality. Constar, Inc. will bear the one-time costs of modifications, and, if needed, removal, to conform to this
requirement at Wantage and Alsip subject to Constar, Inc.’s prior approval. 
  
 11.  Other Development Activities.    Constar, Inc. acknowledges that the Crown Entities currently undertake, and may undertake in the future, various research and development activities for other
businesses. Subject to Sections 6 and 9, nothing in this Agreement shall be construed to prohibit the Crown Entities from continuing to undertake any such activities; provided, that nothing in this Section 11 shall relieve Crown of its obligations
under the Non-Competition Agreement, dated as of the date hereof, between Crown and Constar. 
  
 12.  Indemnification.    With respect to R&D Services, Constar, Inc. shall defend, indemnify and hold the Crown Entities and their Affiliates and their respective officers, directors,
employees, successors and permitted assigns harmless against any and all liability, damage, loss, cost or expense arising out of (i) the provision of R&D Services or any products liability arising therefrom (except any liability directly related
to and directly caused by the gross negligence or willful misconduct of the Crown Entities in providing such R&D Services) and (ii) all claims, suits or actions for bodily injuries suffered in connection with the provision of the R&D
Services and arising out of Constar, Inc.’s breach of this Agreement, negligence or misconduct. Furthermore, Constar, Inc. shall indemnify, defend and hold the Crown Entities and their Affiliates and their respective officers, directors,
employees, successors and permitted assigns harmless against all damages, claims, judgments, decrees, costs, expenses and demands for
 

 
unfair competition or infringement of any United States or foreign trademark or copyright as a direct result of the provision of R&D Services conforming to the specifications required by
Constar, Inc. or the failure of the provision of such R&D Services to comply with any federal, state, local or other law or regulation. The Crown Entities shall not settle any claim for which it is entitled to indemnification hereunder without
the written consent of Purchaser, which shall not be unreasonably withheld. 
  
 13.  Miscellaneous. 
  
 13.1.  Successors/No Third
Party Beneficiaries.    This Agreement shall not be assignable, except that (i) a Crown Entity may, after giving notice to Constar, Inc., assign its rights and obligations under this Agreement; provided, that a Crown
Entity shall not assign its rights and obligations under this Agreement to a competitor of Constar, Inc. in the PET preform and container industry without the prior written consent of Constar, Inc., and (ii) Constar, Inc. may, and hereby gives
notice to Crown that it intends to, pledge its rights and obligations under this Agreement to Constar’s lenders as collateral to secure indebtedness outstanding under Constar’s senior secured credit facility and all renewals, refundings,
refinancings and replacements thereof. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, is intended to
or shall (a) confer on any person other than the parties hereto and their respective successors or permitted assigns any rights (including third party beneficiary rights), remedies, obligations or liabilities under or by reason of this Agreement, or
(b) constitute the parties hereto as partners or as participants in a joint venture. This Agreement shall not provide third parties with any remedy, claim, liability, reimbursement, cause of action or other right in excess of those existing without
reference to the terms of this Agreement. 
  
 13.2.  Force
Majeure.    Neither Supplier nor Purchaser shall be responsible for any failure or delay in performance due to causes beyond their respective control, including, without limitation, earthquake, fire, storm, flood, freeze,
labor disputes, transportation embargoes, acts of God or of any government and acts of war or terrorism (any of the foregoing, a “Force Majeure Event”). Any party, if affected by any such cause, may, upon written notice to the other
parties specifying the reasons therefor, reduce its obligations to the other to the extent it is necessarily prevented, hindered or delayed as a result of the Force Majeure Event. Notwithstanding anything to the contrary in this Agreement, this
provision shall not apply to or otherwise excuse the failure to pay any uncontested R&D Fees or Costs due under this Agreement when due. 
  
 13.3.  Notices.    All notices and other communications required or permitted hereunder shall be in writing, shall be deemed duly given upon actual receipt, and
shall be delivered (a) in person, (b) by registered or certified mail, postage prepaid, return receipt requested or (c) by facsimile or other generally accepted means of electronic transmission (provided that a copy of any notice delivered pursuant
to this clause (c) shall also be sent pursuant to clause (b)), addressed as follows: 
  
 if to
Carnaud, to: 

  
 CarnaudMetalbox plc 
 Downsview Road 
 Wantage 
 Oxfordshire OX12 9 BP 
 Attention:

 Facsimile: 44.1235.402578 
  
 If to Crown Technologies, to: 
  
 Crown Cork &
Seal Technologies Corporation 
 11535 S. Central Avenue 
 Alsip, IL 60482-2523 
 Attention: 
 Facsimile: 
  
 if to either Crown Entity, with a copy to: 
  
 Crown Cork & Seal Company, Inc.

 One Crown Way 
 Philadelphia, PA 19154 
 Attention: 
 Facsimile: 
  
 if to Constar, Inc., to: 

 
 Constar, Inc. 
 One Crown Way 
 Philadelphia, PA 19154-4599 
 Attention: Chief Financial Officer 
 Facsimile: 
  
 or to such other addresses or telecopy numbers as may be specified by like notice to the other parties. 

 
 13.4.  Governing Law.    This Agreement shall be governed by and construed
in accordance with the laws of the Commonwealth of Pennsylvania. 
  
 13.5.  Dispute
Resolution: Negotiation and Arbitration. 
  
 (a)  The parties shall attempt to resolve
any dispute arising out of or relating to this Agreement promptly by negotiation in good faith between executives who have authority to settle the dispute. A party shall give the other parties written notice of any dispute not resolved in the
ordinary course of business. Within ten Business Days after delivery of such notice, the party receiving notice shall submit to the others a written response thereto. The notice and the
 

 
response shall include: (i) a statement of each party’s position(s) regarding the matter(s) in dispute and a summary of arguments in support thereof, and (ii) the name and title of the
executive who will represent that party and any other Person who will accompany that executive. 
  
 (b)  Within 10 Business Days after delivery of the notice, the designated executives shall meet at a mutually acceptable time and place, and thereafter, as often as they reasonably deem necessary, to attempt to resolve the
dispute. All reasonable requests for information made by one party to any other shall be honored in a timely fashion. All negotiations conducted pursuant to this Section 13.5 (and any of the parties’ submissions in contemplation hereof) shall
be deemed Confidential Information and shall be treated by the parties and their representatives as compromise and settlement negotiations under the United States Federal Rules of Evidence and any similar state rules. 
  
 (c)  If the matter in dispute has not been resolved within 30 days after the first meeting of the executives to
attempt to resolve the dispute, either party may submit the dispute to binding arbitration to the Philadelphia, Pennsylvania office of the American Arbitration Association (“AAA”) in accordance with the procedures set forth in the
Commercial Arbitration Rules of the AAA. 
  
 (d)  The Commercial Arbitration Rules of the
AAA, as modified or revised by the provisions of this Section 13.5, shall govern any arbitration proceeding hereunder. The arbitration shall be conducted by three arbitrators selected pursuant to Rule 13 of the Commercial Arbitration Rules, and
pre-hearing discovery shall be permitted if and only to the extent determined by the arbitrator to be necessary in order to effectuate resolution of the matter in dispute. The arbitrator’s decision shall be rendered within 30 days of the
conclusion of any hearing hereunder and the arbitrator’s judgment and award may be entered and enforced in any court of competent jurisdiction. 
  
 (e)  Resolution of disputes under the procedures of this Section 13.5 shall be the sole and exclusive means of resolving disputes arising out of
or relating to this Agreement; provided, however, that nothing herein shall preclude the Parties from seeking in any court of competent jurisdiction temporary or interim injunctive relief to the extent necessary to preserve the subject matter
of the dispute pending resolution under this Section 13.5. 
  
 13.6.  Consent to
Jurisdiction.    The Crown Entities and Constar, Inc. hereby agree and consent to be subject to the exclusive jurisdiction of the United States District Court for the Eastern District of Pennsylvania, and in the absence of
such Federal jurisdiction, the parties consent to be subject to the exclusive jurisdiction of any state court located in the City of Philadelphia and hereby waive the right to assert the lack of personal or subject matter jurisdiction or improper
venue in connection with any such suit, action or other proceeding. In furtherance of the foregoing, each of the parties (i) waives the defense of inconvenient forum, (ii) agrees not to commence any suit, action or other proceeding arising out of
this Agreement or any transactions contemplated hereby other than in any such court (other than the mandatory submission to arbitration in accordance with Section 13.5), and (iii) agrees that a final judgment
 

 
in any such suit, action or other proceeding shall be conclusive and may be enforced in other jurisdictions by suit or judgment or in any other manner provided by law. 
  
 13.7.  Entire Agreement.    This Agreement constitutes the entire understanding of
the parties hereto with respect to the subject matter hereof and supersedes any prior agreement or understanding, written or oral, relating to the subject matter of this Agreement. 
  
 13.8.  Section Headings; Interpretive Issues.    The section and paragraph headings contained in this Agreement are for
reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement. The Crown Entities and Constar, Inc. have participated jointly in the drafting and negotiation of this Agreement. In the event any ambiguity or
question of interpretation or intent arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of
this Agreement. 
  
 13.9.  Counterparts.    This Agreement and
any amendments hereto may be executed in any number of counterparts, each of which shall be deemed an original instrument, but all of which together shall constitute but one and the same agreement. Delivery of an executed counterpart of a signature
page to this Agreement by facsimile shall be as effective as delivery of a manually executed counterpart of this Agreement. 
  
 13.10.  Severability.    If any term or provision of this Agreement or the application thereof to any person or circumstance shall, to any extent, be held invalid
or unenforceable by a court of competent jurisdiction, the remainder of this Agreement or the application of any such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall not be
affected thereby, and each term and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. If any of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to
duration, scope, activity or subject, it shall be construed by limiting and reducing it, so as to be valid and enforceable to the extent compatible with the applicable law or the determination by a court of competent jurisdiction. 

 
 13.11.  Effectiveness.    The terms of this Agreement shall not become
effective until the Initial Public Offering Date. 
  
 13.12.  Pronouns.    Whenever the context may require, any pronouns used herein shall be deemed also to include the corresponding neuter, masculine or feminine forms. 
  
 13.13.  Further Assurances.    The parties shall execute, acknowledge and deliver, or
cause to be executed, acknowledged and delivered, such instruments and take such other action as may be necessary or advisable to carry out their obligations under this Agreement and under any exhibit, document or other instrument delivered pursuant
hereto. 
  
 13.14.  Amendment and Modification.    This
Agreement may not be amended or modified except by written instrument duly executed by the parties hereto. No course of dealing between
 

 
or among any persons having any interest in this Agreement will be deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations of any person under or by
reason of this Agreement. 
  
 [Signatures appear on next page] 
  

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on the day and year first above written.

  
 
	 CARNAUDMETALBOX PLC
 
	 
	 By:
 	 	 /s/    NAME        
 

	  	 	 Name
 Title

 
  
 
	 CROWN CORK & SEAL TECHNOLOGIES CORPORATION
 
	 
	 By:
 	 	 /s/    NAME        
 

	  	 	 Name
 Title

 
  
 
	 CONSTAR, INC.
 
	 
	 By:
 	 	 /s/    NAME        
 

	  	 	 Name
 Title

 

 SCHEDULE A—KEY INDIVIDUALS 
  
 Key Crown Individuals 
  
  
	 Name
 
	    	 Commitment Percentage
 
	    	 Commitment Period
 
	  	 [***]
 

	 [***]
 	    	 50%
 	    	 From the Initial Public Offering Date until 6 months after the Initial Public Offering Date
 	  	 [***]
 
	 
	 [***]
 	    	 30%
 	    	 From 6 months after the Initial Public Offering Date until December 31, 2003
 	  	 [***]
 
	 
	 [***]
 	    	 25%
 	    	 From the Initial Public Offering Date until 6 months from the Initial Public Offering Date
 	  	 [***]
 
	 
	 [***]
 	    	 20%
 	    	 From 6 months after the Initial Public Offering Date until December 31, 2003
 	  	 [***]
 
	 
	 [***]
 	    	 50%
 	    	 From the Initial Public Offering Date until 6 months from the Initial Public Offering Date
 	  	 [***]
 

 
   
 Key Carnaud Individuals 
  

 
	 Name
 
	    	 Commitment Percentage
 
	    	 Commitment Period
 
	  	 [***]
 

	 [***]
 	    	 100%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 [***]
 
	 
	 [***]
 	    	 40%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 [***]
 
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 [***]
 

 
  

	[***]
	 
	Confidential treatment requested 
 

  
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 [***]  
 	   
 
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 [***]  
 	   
 
	 
	 [***]
 	    	 40%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 [
 	 ***]
 

 
   
 Key Transferred Individuals (*)—Crown Technologies 

 
  
	 Name
 
	    	 Commitment Percentage
 
	  	 Commitment Period
 

	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 

 
  

	[***]
	 
	Confidential treatment requested 
 

   
	 
	 [***]
 	  	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	  	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 

 
   

	(*)
	 
	Employment shall be terminated by the applicable Crown Entity and employment will be offered by Constar, Inc. pursuant to the terms of the Benefits Allocation
Agreement. In accordance with the Benefits Allocation Agreement, such termination and offer of employment shall occur (i) with respect to Key Transferred Individuals who, as of the Initial Public Offering Date, are in the process of seeking
permanent residency in the United States, the later of (x) 6 months from the Initial Public Offering Date and (y) the date that such permanent residency is granted and (ii) with respect to Key Transferred Individuals who, as of the Initial Public
Offering Date, are not in the process of seeking permanent residency in the United States, 6 months from the Initial Public Offering Date. 
 

  
 A Key Individual’s available hours for each month shall equal: 
  
 (1)  the Key Individual’s Commitment Percentage (as set forth above) 
  
 multiplied by

  
 (2) 
  
 (a)  with respect to Key Carnaud Individuals, 7.5 hours per day times the number of calendar days in the month, which number of hours (i) shall be reduced by 7.5 hours per day times the
number of Saturdays and Sundays during the month, and (ii) shall be further reduced by all hours during the month that the Key Carnaud Individual charges to holidays, vacation days, sick days and other personal time to which such Key Carnaud
Individual is entitled under the terms of his employment with Carnaud; and 
  
 (b)  with respect to Key
Crown Individuals and Key Transferred Individuals, 8 hours per day times the number of calendar days in the month, which number of hours (i) shall be reduced by 8 hours per day times the number of Saturdays and Sundays during the month, and (ii)
shall be further reduced by all hours during the month that the Key Individual charges to holidays, vacation days, sick days and other personal time to which such Key Individual is entitled under the terms of his employment with Crown Technologies.

  
 In the event that a Key Individual’s Commitment Period begins or ends in the middle of a month available
hours for such month shall be prorated accordingly. 
 

	[***]
	 
	Confidential treatment requested 
 

 SCHEDULE B—NON-DEDICATED EQUIPMENT 
  
 Crown Technologies (Alsip): 
  

	·
	 
	Nissei injection molder 
 

  

	·
	 
	Oberburg compression molder 
 

  

	·
	 
	AHP slitter 
 

  

	·
	 
	Netstal injection molder and ancillaries 
 

  

	·
	 
	Ancillary equipment like A frames etc. 
 

  

	·
	 
	The remaining quality lab equipment including: torque meter, capping machine and the cap dimensional measurement device. 
 

 

	·
	 
	Existing Illiop Machine (will be transferred after new Illiop machine is deemed fully operational pursuant to the terms of this Agreement) 

  

	·
	 
	New Illiop Machine (when constructed pursuant to the terms of this Agreement) 
 

  

Carnaud (Wantage): 
  

	·
	 
	Extrusion blow molder 
 

  

	·
	 
	Oxysense analysis system 
 

  

	·
	 
	Filling equipment 
 

 SCHEDULE C—CONSTAR, INC. WANTAGE EQUIPMENT 
  

	·
	 
	Starshield coating line 
 

  

	·
	 
	Blow molder LBO1E 
 

  

	·
	 
	Blow molder LBO1 
 

  

	·
	 
	Gawis bottle measuring equipment 
 

  

	·
	 
	Bottle trimmer 
 

  

	·
	 
	Bottle section weight cutter 
 

  

	·
	 
	Illiop machine 
 

  

	·
	 
	Magnamike measuring devicePrepared by R.R. Donnelley Financial -- Voghera PET Preform Supply Agreement

  Confidential treatment has been requested by 
   Constar International Inc. pursuant to Rule 406. 
   All non-public information has been
filed 
   with the Securities and Exchange Commission. 
   
 Exhibit 10.11 
  
 VOGHERA PET PREFORM SUPPLY AND LEASE OF RELATED ASSETS AGREEMENT 
  
 THIS IS A VOGHERA PET
PREFORM SUPPLY AND LEASE OF RELATED ASSETS AGREEMENT (the “Agreement”), dated as of                  , 2002, by and among Crown Cork Italy S.p.A., an
indirect subsidiary of Crown (“Supplier”) and Constar Plastics of Italy S.r.l., an indirect subsidiary of Constar (“Purchaser”). 
  
 Background 
  
 Supplier will supply directly to the Constar
Customers on Purchaser’s behalf and Purchaser will purchase from Supplier on the terms and conditions set forth herein, PET preforms presently manufactured at Supplier’s facility in Voghera, Italy (the “Voghera Facility”).

  
 Terms 
  
 NOW, THEREFORE, in consideration of the mutual covenants herein and intending to be legally bound hereby, the parties hereto agree as follows: 
  
 ARTICLE I 
  
 DEFINITIONS

  
 1.1.    Certain Definitions.    Capitalized terms not defined in
this Agreement shall have the meanings ascribed to them in the Corporate Agreement, dated as of the date hereof, between Crown and Constar. As used in this Agreement, the following terms shall have the respective meanings set forth below:

  
 1.1.1.    “AAA” has the meaning set forth in Section 7.4.

  
 1.1.2.    “Affiliate” of any Person means any Person,
directly or indirectly, controlling, controlled by or under common control with such Person. 
  
 1.1.3.    “Agreement” has the meaning set forth in the preamble to the Agreement. 
  
 1.1.4.    “Bankruptcy Event” means with respect to any party, as applicable, (a) the making by such party of any assignment for the benefit of creditors of all or
substantially all of its assets or the admission by such party in writing of inability to pay all or substantially all of its debts as they become due; (b) the adjudication of such party as bankrupt or insolvent or the filing by such party of a
petition or application to any tribunal for the appointment of a trustee or receiver for such party or any substantial part of the assets of such party; or (c) the

 
commencement of any voluntary or involuntary bankruptcy proceedings (and, with respect to involuntary bankruptcy proceedings, the failure to be discharged within 60 days), reorganization
proceedings or similar proceeding with respect to such party or the entry of an order appointing a trustee or receiver or approving a petition in any such proceeding. 
  
 1.1.5.    “Business Day” shall mean any day other than a Saturday, a Sunday or a day on which banks in Rome, Italy are
authorized or obligated by law or executive order to not open or remain closed. 
  
 1.1.6.    “Constar” means Constar International Inc., a Delaware corporation. 
  
 1.1.7.    “Constar Customers” has the meaning set forth in Section 2.1. 
  
 1.1.8.    “Control,” “controlled by” and “under common control with”, as applied to
any Person, means the possession, directly or indirectly, of the power to direct the vote of a majority of the votes that may be cast in the election of directors (or other Persons acting in similar capacities) of such Person or otherwise to direct
or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or by contract or otherwise. 
  
 1.1.9.    “Crown” means Crown Cork & Seal Company, Inc., a Pennsylvania corporation. 
  
 1.1.10.    “Force Majeure Event” has the meaning set forth in Section 6.4.

  
 1.1.11.    “Initial Term” has the meaning set forth in
Section 6.1. 
  
 1.1.12.    “Lease” has the meaning set forth in
Section 5.1. 
  
 1.1.13.    “Person” means an individual, a
corporation, a partnership, an association, a governmental entity, a trust or other entity or organization. 
  
 1.1.14.    “PET” shall mean polyethylene terephthalate. 
  
 1.1.15.    “PET Preforms” means all existing types of PET preforms manufactured at the Voghera Facility as of the Initial Public Offering Date, which types of PET preforms are set forth, for the
avoidance of doubt, on Schedule A hereto (the “Existing PET Preforms”). PET Preforms shall also include any other PET preforms that are identified and mutually agreed upon by Supplier and Purchaser after the Initial Public
Offering Date from time to time (the “New PET Preforms”). 
  
 1.1.16.    “Production Request” has the meaning set forth in Section 2.1. 
  
 1.1.17.    “Purchaser” has the meaning set forth in the preamble to the Agreement. 
  
 1.1.18.    “Release Request” has the meaning set forth in Section 2.1. 
 

 2 

  
 1.1.19.    “Supplier” has
the meaning set forth in the Preamble to the Agreement. 
  
 1.1.20.    “Term” has the meaning set forth in Section 6.1. 
  
 1.1.21.    “Transfer Date” has the meaning set forth in Section 5.1. 
  
 1.1.22.    “Voghera Assets” means those assets set forth in Schedule C. 
  
 1.1.23.    “Voghera Facility” has the meaning set forth in the Background section of this Agreement. 
  
 ARTICLE II 
  
 PURCHASE
OF REQUIREMENTS 
  
 2.1.    Purchase Requirements.

  
 (a)  Subject to the other provisions of this Article II, Purchaser agrees to purchase from Supplier
100% of Purchaser’s requirements for PET Preforms for Purchaser’s customers specified on Schedule B hereto (the “Constar Customers”). 
  
 (b)  At least 31 days prior to the beginning of each year, Purchaser shall provide Supplier with a non-binding forecast for the PET Preforms that it will purchase
from Supplier during such year, which shall represent a good faith estimate of Purchaser’s requirements for PET Preforms for the Constar Customers. On or before the 15th day of each month, Purchaser shall submit a firm order for production during the following month (a “Production Request”), which
shall not exceed [***] PET Preforms, and a non-binding forecast for the following two months, which forecast shall represent a good faith estimate of Purchaser’s requirements for such two months. Purchaser shall be deemed to purchase, and shall
be responsible for payment to Supplier for, any PET Preforms manufactured by Supplier in response to a Production Request, regardless of whether Purchaser submits a Release Request for such PET Preforms. In addition, to maximize utilization of the
Voghera Assets, Supplier may produce PET Preforms based upon Purchaser’s non-binding forecasts. If Purchaser provides its written consent to such production, Purchaser shall be deemed to purchase, and shall be responsible for payment to
Supplier for, any PET Preforms manufactured by Supplier in response to such forecast, regardless of whether Purchaser submits a Release Request for such PET Preforms. At any time that Supplier is holding greater than [***] PET Preforms in inventory
at the Voghera Facility in response to Production Requests or approved production based on Purchaser’s forecasts, Supplier shall promptly notify Purchaser of the number and type of PET Preforms held in inventory and shall not be obligated to
accept Production Requests or to produce and hold PET Preforms until such inventory is reduced below [***] PET Preforms. 
  
 (c)  From time to time Purchaser may submit requests to release PET Preforms for shipment (“Release Requests”) to Supplier. So long as the aggregate amount of PET Preforms released during a month does not
exceed that month’s Production Request and agreed existing 
 

	[***]
	 
	Confidential treatment requested 
 

  
 

 3 

 
stockholdings, Supplier shall satisfy any Release Request; provided, that Supplier shall not be obligated, but shall use commercially reasonable efforts, to ship PET Preforms pursuant to a
Release Request on less than 5 days notice. In the event that the aggregate amount of PET Preforms released during a month exceeds that month’s Production Request and agreed existing stockholdings, Supplier shall use its commercially reasonable
efforts to satisfy the Release Request; provided, however, that in no event shall Supplier be obligated to utilize production equipment other than the Voghera Assets. With respect to Release Requests that (in the aggregate, if
applicable) do not exceed the relevant month’s Production Request, Supplier will ship no less than [***] of the released PET Preforms to the Constar Customers, as directed by Purchaser, OTIF (on time, in full). The measurement of OTIF shipments
shall conform to historic practices of the Voghera Facility. If Supplier is unable to satisfy a Release Request, Supplier shall promptly notify Purchaser. After such notification, Purchaser may, at its option, direct Supplier to resequence
utilization of the Voghera Assets to satisfy the Release Request; provided, however, that, in the event that the aggregate amount of PET Preforms released during a month exceeds that month’s Production Request, Supplier shall be
under no obligation to resequence utilization of the Voghera Assets if such resequencing would adversely effect Supplier’s other operations at the Voghera Facility. If Supplier is unable to satisfy a Release Request that (in the aggregate, if
applicable) did not exceed the relevant month’s Production Request and Purchaser is able to secure an alternative supply, such PET Preforms shall not be included in calculating the requirements commitment in clause (a) above. Purchaser shall be
deemed to purchase, and shall be responsible for payment to Supplier for, any PET Preforms shipped by Supplier in response to a Release Request, regardless of whether the Constar Customer ultimately pays Purchaser for such PET Preforms. Supplier
shall not be responsible for collecting payment from the Constar Customer for PET Preforms manufactured and shipped hereunder. 
  
 (d)  Consistent with historic practices at the Voghera Facility, Purchaser shall provide Supplier, or shall direct the Constar Customers to provide Supplier, at Supplier’s cost, with resin necessary to produce the PET
Preforms. Supplier shall not be deemed to breach this Agreement as a result of, and shall have no liability to Purchaser for, any failure to perform its obligations hereunder that results from the failure of Purchaser or the Constar Customers to
provide Supplier with resin necessary to produce the PET Preforms. 
  
 (e)  Within 30 calendar days of the
end of each three-month period ending March 31, June 30, September 30 and December 31 of each year during the Term, Purchaser shall provide Supplier a certificate from a member of it’s senior management attesting to Purchaser’s conformance
to its obligations under Section 2.1(a) of this Agreement during such three-month period. If Purchaser does not provide such certificate to Supplier within such 30 calendar day period or upon Supplier’s request, Purchaser shall permit
Supplier’s outside accountants to access the books and records of Purchaser in order to review the books and records relating to purchases of such PET Preforms by the Constar Customers. 
  
 (f)  Notwithstanding the foregoing, Supplier shall not be required to manufacture and/or ship any specific PET Preforms if Supplier reasonably determines that any
such 
  
 

	[***]
	 
	Confidential treatment requested 
 

 

 4 

  
 manufacture or shipment will result in a material violation of any applicable governmental laws or
regulations. 
  
 (g)  The parties agree to use good faith efforts to modify the provisions of this Section
2 if either party is unsatisfied with the operation of such provisions; provided, that no party shall be under any obligation to agree to any such changes. 
  
 ARTICLE III 
  
 PRICE 
  
 3.1.    Pricing.    (a)  For Existing PET Preforms, Purchaser will pay to
Supplier the prices set forth on Schedule A hereto for the relevant PET Preforms purchased pursuant to this Agreement. 
  
 (b)  For New PET Preforms, mutually agreeable pricing will be established between Supplier and Purchaser on a case-by-case basis. Supplier shall have no obligation to supply, and Purchaser shall have no obligation to
purchase, New PET Preforms for which pricing cannot be agreed upon and any such New PET Preforms shall not be calculated in the requirements commitment set forth in Section 2.1(a). If pricing of New PET Preforms is agreed upon, such New PET Preforms
shall be calculated in such requirements commitment. 
  
 ARTICLE IV 
  
 DELIVERY 
  
 4.1.    Delivery.    Delivery of all PET Preforms sold under this Agreement shall be F.O.B. Supplier at the Voghera Facility. Title and risk of loss or damages to all PET Preforms shall
pass to Purchaser upon shipment, F.O.B. point, by Supplier to Purchaser. Purchaser shall pay for all freight and other costs associated with shipment of PET Preforms to the location of delivery. For PET Preforms delivered F.O.B. Supplier, Supplier
shall furnish the facilities and personnel for loading PET Preforms at the F.O.B. point. 
  
 4.2.    Payment.    Supplier shall provide invoices to Purchaser for PET Preforms and, if applicable, shipping or other charges upon the earlier of (i) release of such PET Preforms
pursuant to a Release Request or (ii) 90 days from the date of acceptance of the Production Request pursuant to which such PET Preforms were produced. All invoices from Supplier to Purchaser for PET Preforms shall be paid by Purchaser on a net-40
days basis from the end of the month in which such invoice was dated. 
 

 5 

  
 ARTICLE V 
  
 LEASE OF RELATED ASSETS 
  
 5.1.    Lease and Removal of Voghera Assets.    The Voghera Assets shall remain at the Voghera Facility and Supplier shall, subject to the terms and
conditions set forth in this Article V, lease the Voghera Assets from Purchaser for the Term (the “Lease”). Within 90 days after the last day of the Term, Purchaser shall remove, at its expense, and shall be solely responsible for
removing, the Voghera Assets from the Voghera Facility (the “Transfer Date”). Purchaser shall provide Supplier with written notice of the Transfer Date at least 60 Business Days prior to the Transfer Date. If the Voghera Assets
shall not be removed on or prior to the Transfer Date, Purchaser shall reimburse Supplier all costs and expenses incurred by Supplier on account of maintaining and storing the Voghera Assets at the Voghera Facility, and any other incidental,
consequential or other damages or losses incurred by Supplier as a result of such non-removal until Purchaser removes the Voghera Assets. Notwithstanding the preceding sentence or anything else in this Agreement to the contrary, Supplier shall have
no responsibilities or obligations of any kind, including, without limitation, as to operation, storage, insurance or maintenance, with respect to the Voghera Assets after the Transfer Date. 
  
 5.2.    Rent.    Consideration for the lease of Voghera Assets from Purchaser to Supplier for the Term is incorporated in the
prices for Existing PET Preforms included in Schedule A and will be included in the prices for any New PET Preforms. 
  
 5.3.    Insurance.    Supplier shall maintain adequate insurance with respect to the Voghera Assets insuring against such risks customarily insured against in accordance with
Supplier’s practice until their removal from the Voghera Facility by Purchaser in accordance with Section 5.1 or until 90 days after the Term, whichever is earlier. Supplier shall, upon Purchaser’s reasonable request, provide evidence of
insurance and appropriate loss payable endorsements in favor of Purchaser. Purchaser hereby assumes and shall bear the entire risk of damage, whether or not insured against, of the Voghera Assets arising out of the operation of the Voghera Assets or
arising out of Purchaser’s breach of this Agreement, negligence or willful misconduct. 
  
 5.4.    Maintenance and Improvements.    During the Term, Supplier shall perform all maintenance reasonably required to keep the Voghera Assets in good operating order, repair, condition
and appearance and in accordance with normal industry standards, normal wear and tear and impairments of value excepted. Notwithstanding the foregoing, Purchaser, and not Supplier or any of its Affiliates, shall be obliged to conduct, or cause to be
conducted, mold refurbishments reasonably required to maintain the Voghera Assets and shall be responsible for the cost of repairing or replacing any Voghera Assets that are defective or malfunctioning (except to the extent that such defects or
malfunctions arise as a result of Supplier’s failure to maintain the Voghera Assets in accordance with the first sentence of this Section 5.4). Prior to the start of each calendar year, Supplier shall provide Purchaser with an estimate of
capital investments with respect to the Voghera assets for the next year. Neither Supplier nor any of its

 

 6 

 
Affiliates shall make any capital expenditures in respect of capital investments with respect to the Voghera Assets without the prior written consent of Purchaser. Upon receipt of such consent,
Supplier shall make, or cause to be made, such capital expenditures and shall invoice Purchaser for any expenses incurred in undertaking such capital expenditures. If Purchaser does not consent to, or agree to reimburse Supplier for any such capital
expenditures, neither Supplier nor any of its Affiliates shall have any obligation to make such capital expenditures and none of them shall be liable for any interruptions or deficiencies if the supply of PET Preforms under this Agreement, any
deterioration of the Voghera Assets or any other liability, arising out of or resulting from the failure to make any such capital expenditure. The parties agree that capital expenditures subject to approval and reimbursement by Purchaser shall not
include costs associated with routine maintenance (other than mold refurbishments) covered by the first sentence of this Section 5.4. 
  
 5.5.    Warranties.    During the Term, Purchaser assigns to Supplier, and Supplier may have the benefit of any and all manufacturers’ warranties, service agreements and
patent indemnities (copies of same to be provided to Supplier), if any, with respect to the Voghera Assets, to the extent assignable by Purchaser, until they are removed by Purchaser. 
  
 5.6.    No Interference.    Purchaser covenants that it shall not grant or convey any interest that, if used or enjoyed in
accordance with its terms, would interfere with the use, enjoyment, or operation of the Voghera Assets by Supplier, its Affiliates or their respective permitted successors, assigns or subtenants at any time prior to the removal of the Voghera Assets
by Purchaser; provided, that Purchaser shall be permitted to grant a security interest in the Voghera Assets to secure the indebtedness of Purchaser or any of its Affiliates. 
  
 5.7.    Possession and Quiet Enjoyment.    Purchaser covenants with Supplier that Supplier and its Affiliates will enjoy
quiet possession of the Voghera Assets and the right to use the Voghera Assets free from claims of persons in possession and third parties claiming rights thereto. 
  
 5.8.    Access.    Prior to the Transfer Date, representatives of Purchaser may, at their own expense, during normal business
hours and upon reasonable notice, inspect the Voghera Assets and have access to the employees whose primary responsibilities relate to the Voghera Assets; provided, that a representative of Supplier shall be present at all such times; and,
provided, further, that no exercise of such inspection shall materially interfere with the normal operation of the Voghera Assets or the business of Supplier. 
  
 ARTICLE VI 
  
 TERM,
DEFAULT AND OTHER PROVISIONS 
  
 6.1.    Term.    This Agreement shall commence upon the Initial Public Offering Date and shall continue until December 31, 2003 (the “Initial Term”). Purchaser may, at
its option, extend the Initial Term until June 30, 2004 on the terms contained herein (the Initial Term, as so

 

 7 

 
extended, the “Term”), by giving Supplier written notice of such extension no more than 120 or less than 60 days written notice thereof. 
  
  6.2.    Events of Default.    (a)  The following shall be considered events
of default and shall give rise to a right of Supplier to terminate this Agreement within 45 days of Supplier’s discovery of such event of default: (i) Purchaser fails to make timely payments for invoiced PET Products, subject to a 30-day cure
period after notice regarding such breach, (ii) Purchaser materially breaches any other applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such breach or (iii) Purchaser or Constar experiences a change of
Control such that Purchaser or Constar is controlled by a competitor of either Constar or Crown (provided that such termination shall not be effective until six months from the date of the Change of Control). If Purchaser or Constar suffers a
Bankruptcy Event, Supplier shall have the right to unilaterally make reasonable modifications to the payment terms set forth in Section 4.2 of the Agreement at any time after such Bankruptcy Event. Supplier shall promptly notify Purchaser of any
such modifications to the payment terms of this Agreement. 
   
  (b)  The following shall be
considered events of default and shall give rise to a right of Purchaser to terminate this Agreement within 45 days of Purchaser’s discovery of such event of default: (i) Supplier materially breaches any applicable provision of this Agreement,
subject to a 30-day cure period after notice regarding such breach or (ii) Supplier or Crown experiences a change of Control such that Supplier or Crown is controlled by a competitor of either Constar or Crown (provided that such termination shall
not be effective until six months from the date of the Change of Control). 
   
 (c)  Each party shall
provide the other party with prompt notice upon discovery of a default by the other party; provided, that failure to give such notice shall not limit or restrict the ability of a party to terminate this Agreement subject to the cure periods provided
in this Section 6.2. 
  
 6.3.    No Waiver.    If the party not in
default continues to make or accept shipments, as the case may be, despite the other party’s default, such action shall not constitute a waiver of the default, or in any way affect the rights under this Agreement of the party not in default. A
waiver by either party of any breach of any provision shall not constitute a waiver of any other breach of such provision or of any other provision. 
  
 6.4.    Force Majeure.    Neither Supplier nor Purchaser shall be responsible for any failure or delay in performance due to causes beyond the reasonable
control of the affected party that render performance commercially impracticable (a “Force Majeure Event”). Any party, if affected by any such cause, may, upon written notice to the other specifying the reasons therefore, reduce its
obligations to the other by an amount not in excess of the quantity that it is unable to deliver or purchase due to such cause. In the event such a curtailment by either party continues in whole or in part for a period of 5 continuous days, then, in
the case of a Supplier Force Majeure Event, Purchaser may arrange for temporary supply of its requirements until Supplier can resume delivery of PET Preforms to Purchaser, and, in the case of a Purchaser Force Majeure Event, Purchaser shall use its
best efforts to sell to third parties those PET Preforms
 
 

 8 

 
which would have been delivered to the Constar Customers on Purchaser’s behalf (in accordance with Purchaser’s delivery schedule) in the absence of such curtailment. Notwithstanding
anything to the contrary in this Agreement, this provision shall not apply to or otherwise excuse the failure to pay any uncontested costs or fees due under this Agreement when due (including payment for PET Preforms produced in accordance with
Section 2.1(b), regardless of whether Purchaser submits a Release Request for such PET Preforms). 
  
 6.5.    Warranty; Limitation of Liability.    (a)  Supplier warrants that all PET Preforms sold to Purchaser (i) shall be free from defects in workmanship and materials, except
for any defects arising out of actions taken by or at the direction of Purchaser or materials provided by or on behalf of Purchaser and (ii) shall comply with the historical specifications for Existing PET Preforms and with any agreed upon
specifications for New PET Preforms. Supplier’s liability under this warranty, whether in contract or tort, shall be limited exclusively to the repayment of the purchase price of the defective PET Preforms. Supplier will make no other
warranties with respect to the PET Preforms. OTHER THAN THE ABOVE WARRANTY, SUPPLIER MAKES NO WARRANTY, WHETHER OF MERCHANTABILITY, FITNESS OR OTHERWISE, EXPRESS OR IMPLIED, IN FACT OR BY LAW, AND SUPPLIER SHALL HAVE NO FURTHER OBLIGATION OR
LIABILITY UNDER THE ABOVE WARRANTY OR WITH RESPECT TO THE PET PREFORMS. SUBJECT TO THE FOLLOWING SENTENCE, SUPPLIER SHALL IN NO EVENT BE LIABLE FOR PUNITIVE, CONSEQUENTIAL OR INCIDENTAL DAMAGES. 
  

(b)  Purchaser agrees to waive all claims for shortages in the PET Preforms ordered and received hereunder unless such claims are submitted in writing to
Supplier within 30 days after receipt of notice from the Constar Customer of such shortage. 
  
 (c)  Subject to the above provisions, Purchaser shall not bring any other action arising hereunder unless such action is brought within one year after the date such cause of action accrues. 
  
 (d)   Supplier shall not be liable for, and Purchaser assumes responsibility for, all personal injury and property damage
resulting from the handling, possession, use or resale of the PET Preforms produced hereunder after such PET Preforms are delivered to the Constar Customer, whether the same is used alone or in combination with other substances, except to the extent
any such personal injury or property damage results from the willful misconduct of Supplier. 
  
 6.6.    Confidentiality; Disclosures. 
  
 6.6.1.    Confidentiality.    The parties agree (a) to maintain all information, whether in written, oral, electronic or other form, necessary for or utilized or received pursuant to any
terms of this Agreement, as the case may be, including, without limitation, prices, cost components, payment terms, technical knowledge, features, know-how, material, manufacturing, Release Requests, Production Requests, tooling and equipment
specifications and other
 
 

 9 

  
information necessary to carry out the terms of this Agreement, as the case may be (the “Confidential Information”), as secret and confidential and (b) not to disclose the
Confidential Information to any third person or party (except for employees, counsel, contractors, customers, consultants or vendors who have a need to know and are informed of the confidential nature of such information by the disclosing party).
Each party shall accept responsibility and be liable for any disclosure by any third person of any Confidential Information disclosed to such third person by such party. The parties will use the same measures to maintain the confidentiality of the
Confidential Information of any other party in its possession or control that it uses to maintain the confidentiality of its own Confidential Information of similar type and importance.  Notwithstanding the foregoing, either party or their
Affiliates may describe this Agreement in, and include this Agreement with, filings with the U.S. Securities and Exchange Commission and any related prospectuses, including such filings or prospectuses in connection with any offering of securities.
Confidential Information will not include information that (i) is in or enters the public domain without breach of this Agreement, or (ii) the receiving party lawfully receives from a third party without restriction on disclosure and, to the
receiving party’s knowledge, without breach of a nondisclosure obligation. 
   
 6.6.2.    Disclosure to Governmental Agency.    Notwithstanding the foregoing, each party shall be permitted to disclose the Confidential Information and/or any portion thereof (i) to a
governmental agency or authority as required in response to a subpoena therefor, (ii) in connection with formal requests for discovery under applicable rules of civil procedure in a legal action before a court of competent jurisdiction to which such
party is a party and (iii) as otherwise required by law; provided, however, that, in any such case, each party shall notify the other party as early as reasonably practicable prior to disclosure to allow such party to take appropriate
measures to preserve the confidentiality of such information at the expense of such party. 
  
 6.6.3.    Ownership of Information.    All Confidential Information supplied or developed by either party will be and remain the sole and exclusive property of the party who supplied or
developed it; provided, however, that any inventions, discoveries, technical knowledge or know-how relating to the manufacture or sale of PET preforms or containers and arising from the Voghera Assets or the production of PET Preforms
pursuant to this Agreement shall belong exclusively to Purchaser and Supplier hereby irrevocably and unconditionally assigns and transfers to Purchaser all rights of every kind, nature or description that Supplier may have in or to such inventions,
discoveries, technological knowledge or know-how. 
  
 6.6.4.    Return of Confidential
Information.    Upon the written request of a party which has disclosed information covered by Section 6.6 in written, printed or other tangible form, all such readily available information and all copies thereof, including
samples or materials, and all notes or other materials derived from such information shall be returned to the party which disclosed such information. 
 

 10 

  
 6.7.    Right of
Setoff.    Purchaser and Supplier shall waive all rights of setoff and recoupment either may have against the other or any of the other’s Affiliates with respect to all amounts which may be owed from time to time
pursuant to this Agreement. 
  
 6.8.    Indemnification.    With
respect to PET Preforms manufactured by Supplier pursuant to this Agreement, Purchaser shall defend, indemnify and hold Supplier and its Affiliates and their respective officers, directors, employees, successors and permitted assigns harmless
against any and all liability, damage, loss, cost or expense arising out of (i) the manufacture, use or sale of such PET Preforms or any products liability arising therefrom (except any liability directly related to and directly caused by the gross
negligence or willful misconduct of Supplier in manufacturing the PET Preforms) and (ii) all claims, suits or actions for bodily injuries suffered in connection with the operations or maintenance of the Voghera Assets and arising out of
Purchaser’s breach of this Agreement, negligence or willful misconduct. Furthermore, Purchaser shall indemnify, defend and hold Supplier and its Affiliates and their respective officers, directors, employees, successors and permitted assigns
harmless against all damages, claims, judgments, decrees, costs, expenses and demands for unfair competition or infringement of any United States or foreign trademark or copyright as a direct result of Supplier’s manufacture of PET Preforms for
Purchaser conforming to the specifications required by Purchaser or the failure of such conforming PET Preforms to comply with any federal, state, local or other law or regulation. Supplier shall not settle any claim for which it is entitled to
indemnification hereunder without the written consent of Purchaser, which consent shall not be unreasonably withheld. 
  
 ARTICLE VII 
  
 MISCELLANEOUS 
  

7.1.    Notices. 
  
 All notices and other communications required or permitted hereunder shall be in writing, shall be deemed duly given upon actual receipt, and shall be delivered (a) in person, (b) by registered or certified mail, postage prepaid,
return receipt requested or (c) by facsimile or other generally accepted means of electronic transmission (provided that a copy of any notice delivered pursuant to this clause (c) shall also be sent pursuant to clause (b)), addressed as follows:

  
 if to Purchaser, to: 
  
 Constar International Inc. 
 One Crown Way

 Philadelphia, PA 19154-4599 
 Attention: Michael J. Hoffman 
 Facsimile: 
  
 if to Crown, to: 
 

 11 

  
 Crown Cork Italy S.p.A. 
 Via Lomellina 134 
 27058 Voghera

 Attention: Paolo Minardi 
 Facsimile: 
  
 with a copy to 
  

Crown Cork & Seal Company, Inc. 
 One
Crown Way 
 Philadelphia, PA 19154 
 Attention: Facsimile: 
  
 or to such other addresses or telecopy numbers as may be specified by like notice to the other
parties. 
  
 7.2.    Independent Contractor.    None of the parties is
now, nor shall it be made by this Agreement, an agent or legal representative of the other party for any purpose, and neither party has any right or authority to create any obligation, express or implied, on behalf of the other party, to accept any
service of process upon it, or to receive any notices of any kind on its behalf. All activities by Supplier hereunder shall be carried on by Supplier as an independent contractor and not as an agent for Purchaser. 
  
 7.3.    Governing Law.    This Agreement shall be governed by and construed in accordance
with the laws of the Commonwealth of Pennsylvania. 
  
 7.4.    Dispute
Resolution:  Negotiation and Arbitration. 
  
 7.4.1.    The parties shall attempt
to resolve any dispute arising out of or relating to this Agreement promptly by negotiation in good faith between executives who have authority to settle the dispute. A party shall give the other party written notice of any dispute not resolved in
the ordinary course of business. Within 10 Business Days after delivery of such notice, the party receiving notice shall submit to the other a written response thereto. The notice and the response shall include: (i) a statement of each party’s
position(s) regarding the matter(s) in dispute and a summary of arguments in support thereof, and (ii) the name and title of the executive who will represent that party and any other Person who will accompany that executive. 
  
 7.4.2.    Within 10 Business Days after delivery of the notice, the designated executives shall meet at a mutually
acceptable time and place, and thereafter, as often as they reasonably deem necessary, to attempt to resolve the dispute. All reasonable requests for information made by one party to any other shall be honored in a timely fashion. All negotiations
conducted pursuant to this Section 7.4 (and any of the parties’ submissions in
 
 

 12 

 
contemplation hereof) shall be deemed Confidential Information and shall be treated by the parties and their representatives as compromise and settlement negotiations under the United States
Federal Rules of Evidence and any similar state rules. 
  
 7.4.3.    If the matter in dispute has
not been resolved within 30 days after the first meeting of the executives to attempt to resolve the dispute, either party may submit the dispute to binding arbitration to the Philadelphia, Pennsylvania office of the American Arbitration Association
(“AAA”) in accordance with the procedures set forth in the Commercial Arbitration Rules of the AAA. 
  
 7.4.4.    The Commercial Arbitration Rules of the AAA, as modified or revised by the provisions of this Section 7.4, shall govern any arbitration proceeding hereunder. The arbitration shall be conducted by three
arbitrators selected pursuant to Rule 13 of the Commercial Arbitration Rules, and pre-hearing discovery shall be permitted if and only to the extent determined by the arbitrator to be necessary in order to effectuate resolution of the matter in
dispute. The arbitrator’s decision shall be rendered within 30 days of the conclusion of any hearing hereunder and the arbitrator’s judgment and award may be entered and enforced in any court of competent jurisdiction. 

 
 7.4.5.    Resolution of disputes under the procedures of this Section 7.4 shall be the sole and exclusive
means of resolving disputes arising out of or relating to this Agreement; provided, however, that nothing herein shall preclude the Parties from seeking in any court of competent jurisdiction temporary or interim injunctive relief to
the extent necessary to preserve the subject matter of the dispute pending resolution under this Section 7.4. 
  
 7.5.    Consent to Jurisdiction. 
  
 Supplier and Purchaser hereby agree
and consent to be subject to the exclusive jurisdiction of the United States District Court for the Eastern District of Pennsylvania, and in the absence of such Federal jurisdiction, the parties consent to be subject to the exclusive jurisdiction of
any state court located in the City of Philadelphia and hereby waive the right to assert the lack of personal or subject matter jurisdiction or improper venue in connection with any such suit, action or other proceeding. In furtherance of the
foregoing, each of the parties (i) waives the defense of inconvenient forum, (ii) agrees not to commence any suit, action or other proceeding arising out of this Agreement or any transactions contemplated hereby other than in any such court (other
than the mandatory submission to arbitration in accordance with Section 7.4), and (iii) agrees that a final judgment in any such suit, action or other proceeding shall be conclusive and may be enforced in other jurisdictions by suit or judgment or
in any other manner provided by law. 
  
 7.6.    Entire
Agreement.    This Agreement constitutes the entire understanding of the parties hereto with respect to the subject matter hereof and supersedes any prior agreement or understanding, written or oral, relating to the subject
matter of this Agreement. 
 

 13 

  
  7.7.    Successors/No Third Party
Beneficiaries.    This Agreement shall not be assignable, except that (i) Supplier may, after giving notice to Purchaser, assign its rights and obligations under this Agreement so long as the assignee agrees in writing to
assume Supplier’s obligations hereunder; provided, that Supplier shall not assign its rights and obligations under this Agreement to a competitor of Purchaser in the PET preform and container industry without the prior written consent of
Purchaser, and (ii) Purchaser may, and hereby gives notice to Supplier that it intends to, pledge its rights and obligations under this Agreement to its lenders as collateral to secure indebtedness outstanding under its senior secured credit
facility and all renewals, refundings, refinancings and replacements thereof. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and permitted assigns. Nothing in this
Agreement, express or implied, is intended to or shall (a) confer on any person other than the parties hereto and their respective successors or permitted assigns any rights (including third party beneficiary rights), remedies, obligations or
liabilities under or by reason of this Agreement, or (b) constitute the parties hereto as partners or as participants in a joint venture. This Agreement shall not provide third parties with any remedy, claim, liability, reimbursement, cause of
action or other right in excess of those existing without reference to the terms of this Agreement. 
   
 7.8.     Severability.    If any term or provision of this Agreement or the application thereof to any person or circumstance shall, to any extent, be held invalid or unenforceable by a
court of competent jurisdiction, the remainder of this Agreement or the application of any such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall not be affected thereby, and each
term and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. If any of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, scope, activity or
subject, it shall be construed by limiting and reducing it, so as to be valid and enforceable to the extent compatible with the applicable law or the determination by a court of competent jurisdiction. 
  
 7.9.    Counterparts.    This Agreement and any amendments hereto may be executed in any
number of counterparts, each of which shall be deemed an original instrument, but all of which together shall constitute but one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile shall be
as effective as delivery of a manually executed counterpart of this Agreement. 
  
 7.10.    Section Headings; Interpretive Issues.    The section and paragraph headings contained in this Agreement are for reference purposes only and shall not in any way affect the
meaning or interpretation of this Agreement. Supplier and Purchaser have participated jointly in the drafting and negotiation of this Agreement. In the event any ambiguity or question of interpretation or intent arises, this Agreement shall be
construed as if drafted jointly by Supplier and Purchaser and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement. 
 

 14 

  
 7.11.    Effectiveness.    The
terms of this Agreement shall not become effective until the Initial Public Offering Date. 
  
 7.12    Pronouns.    Whenever the context may require, any pronouns used herein shall be deemed also to include the corresponding neuter, masculine or feminine forms. 

 
 7.13.    Further Assurances.    The parties shall execute, acknowledge and
deliver, or cause to be executed, acknowledged and delivered, such instruments and take such other action as may be necessary or advisable to carry out their obligations under this Agreement and under any exhibit, document or other instrument
delivered pursuant hereto. 
  
 7.14.    Amendment and
Modification.    This Agreement may not be amended or modified except by written instrument duly executed by the parties hereto. No course of dealing between or among any persons having any interest in this Agreement will be
deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations of any person under or by reason of this Agreement. 
 

 15 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

  
 CONSTAR PLASTICS OF ITALY S.R.L.

  
 By:                                     
                                        
                    
 Name: 
 Title: 
  
 CROWN CORK ITALY S.P.A. 
  
 By:                                     
                                        
                    
 Name: 
 Title: 
 

 16 

   Schedule A 
   
  Existing PET Preforms and Prices 
   
  In EUR 

	 Preform cost 
 
	  	 28g
 
	  	 47g
 
	  	  
	 PET resin
 	  	 X
 	  	 X
 	  	 (assumes 1% spoilage)
 
	 Masterbatch
 	  	 X
 	  	 X
 	  	 (assumes 1% spoilage)
 
	 Voghera conversion cost, includes packaging
 	  	 [***]
 	  	 [***]
 	  	  
	  	  	 
	  	 
	  	  
	 Ex-works price
 	  	 X
 	  	 X
 	  	  
	  	  	 
	  	 
	  	  

 
   
  PET resin = preform weight in grammes x % PET x PET price x [***] 

  
  Masterbatch = preform weight in grammes x % masterbatch x masterbatch price x [***] 
   
  Voghera conversion costs assumes that the PET equipment sold to Constar is being leased back for [***] rent 
  
 [***]  Confidential treatment requested 

  Schedule B 
    
  Constar Customers 
   
  [***] and any other Affiliates of [***] located
in Italy 
   
 

	[***]
	 
	Confidential treatment requested 
 

 Schedule C 
  
 Voghera Assets 
  
 [***] 
  
 

	[***]
	 
	Confidential treatment requested

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}]]